Diocto Stool Softener Recalled for Infection Risk
How Do Stool Softeners Work?
Stool softeners work by increasing the amount of water that gets absorbed into the intestines and helps to make stool soft so that it can pass without difficulty. People who suffer from constipation, have had surgery, or women who have just given birth, are often given stool softeners to reduce strain and pain during bowel movements.
What Prompted the Recall?
The product in question, Diocto Stool Softener has been sold to people in 473 ml bottles, but only lots with NDC 0536-0590-85 listed have been included in the recall. The potential risk of infection was brought to the attention of the manufacturer, PharmaTech LLC in Davie, Florida, because of two cases that had come about.
What are the Signs and Symptoms of the Infection?
The infections are potentially life-threatening because B. cepacia doesn’t respond well to common antibiotics. If you have this product in your home, or if a loved one has used this product recently, stop using it immediately and watch for some of the common signs and symptoms of B. cepacia. These include fever, coughing, congestion, shortness of breath, and wheezing. This type of infection causes problems in the lungs and can lead to deterioration of the lung tissue if left untreated. If you think you are experiencing a B. cepacia infection, contact your local health authority as soon as possible.
What’s Being Done About the Recall?
There are a number of lawsuits coming about as a result of the bacteria found in Diocto Stool Softener product. One law firm, Hastings Law, is extending an invitation to victims and their families of people who have suffered. They are taking on new clients for a B. cepacia bacterial infection lawsuit. This is the second time in almost a year that the company, PharmaTech LLC has had to issue a recall for one of its products. Both recalls were based on evidence of B. cepacia found in their products.
What Else Do You Need to Know?
The U.S. Food and Drug Administration (FDA) is encouraging people to report any signs and symptoms of the B. cepacia bacterial infection using their hotline or online through their website. What’s more, in an effort to reduce the risk of further infection, the FDA has recommended that people who are using liquid forms of docusate, the active ingredient in stool softeners, stop using them immediately and determine the manufacturer before proceeding with its use. The products may have been distributed by a number of retailers under several brands, as is the case with many medications and treatments.